AGP Executive Report
Last update: 9 hours agoMedicare Meets CBD: A new Medicare pilot will cover hemp-derived CBD for certain patients, even as Congress moves toward a law that could effectively remove many hemp-derived THC products from the market—creating a policy clash that could disrupt patient access and the industry. Hemp Industry Shockwave: A new economic report warns a Dec. 11 ban on hemp-derived THC products could shut down about 68% of U.S. hemp-related businesses, underscoring how fast rules can hit supply chains. Caregiver Strain: New survey data finds 7 in 10 carers say a loved one’s chronic illness has harmed their mental health, with many reporting anxiety, isolation, and lost personal time. Regulation Pressure on Kratom: Coverage highlights rising kratom/7-OH exposure reports and growing enforcement moves, as doctors weigh the risk of bans for current users. Cannabis Court/Enforcement: UK reporting details a jailed man tied to a cannabis farm after police found plants and equipment; Malaysia court updates show prosecutors seeking to serve an appeal notice in a cannabis trafficking case. CBD in Consumer Culture: Kendall Jenner buys into Trip, a CBD drinks brand, signaling mainstream marketing momentum for hemp-derived wellness products. Medical Cannabis Supply: Dunbar Pharma says it will showcase its plant-derived dronabinol API capabilities at expopharm 2026 in Munich.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
